TARGETING LSD1 EPIGENETIC SIGNATURE IN CASTRATION-RECURRENT PROSTATE CANCER

$123,732FY2013Department of the ArmyDOD

Health Research, Inc., Rockville MD

Investigators

View source on USAspending →